Nirmala Bhoopalam

1.0k total citations
42 papers, 791 citations indexed

About

Nirmala Bhoopalam is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Nirmala Bhoopalam has authored 42 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 15 papers in Hematology and 11 papers in Molecular Biology. Recurrent topics in Nirmala Bhoopalam's work include Multiple Myeloma Research and Treatments (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Bone health and treatments (5 papers). Nirmala Bhoopalam is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Bone health and treatments (5 papers). Nirmala Bhoopalam collaborates with scholars based in United States, Germany and Israel. Nirmala Bhoopalam's co-authors include Paul Heller, Vincent Yakulis, Morris A. Fisher, Nicolas Costea, John R. Wilson, Jun Minowada, Mary Beth Klein, Gerhard Gaedicke, Ralph J. Hauke and Philip J. Saylor and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Nirmala Bhoopalam

40 papers receiving 715 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nirmala Bhoopalam United States 15 354 268 197 184 138 42 791
Anna Butturini United States 17 301 0.9× 100 0.4× 82 0.4× 117 0.6× 258 1.9× 48 1.1k
Richard Delarue France 17 617 1.7× 136 0.5× 103 0.5× 209 1.1× 229 1.7× 47 1.2k
Stella D’Oronzo Italy 21 594 1.7× 209 0.8× 124 0.6× 85 0.5× 421 3.1× 46 1.1k
Fang Li China 14 268 0.8× 289 1.1× 84 0.4× 45 0.2× 126 0.9× 84 610
María‐Eugenia Miranda‐Carús Spain 17 126 0.4× 73 0.3× 120 0.6× 529 2.9× 188 1.4× 30 1.0k
Shizuyo Tsujimura Japan 16 234 0.7× 92 0.3× 224 1.1× 286 1.6× 101 0.7× 33 969
J. Box United States 7 101 0.3× 51 0.2× 204 1.0× 367 2.0× 64 0.5× 10 1.1k
Marie-Joëlle Kaiser Belgium 15 78 0.2× 69 0.3× 111 0.6× 127 0.7× 129 0.9× 21 823
Maria Melachrinou Greece 17 166 0.5× 131 0.5× 53 0.3× 118 0.6× 231 1.7× 54 722
Vincenzo Pitini Italy 15 236 0.7× 162 0.6× 17 0.1× 92 0.5× 141 1.0× 48 729

Countries citing papers authored by Nirmala Bhoopalam

Since Specialization
Citations

This map shows the geographic impact of Nirmala Bhoopalam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nirmala Bhoopalam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nirmala Bhoopalam more than expected).

Fields of papers citing papers by Nirmala Bhoopalam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nirmala Bhoopalam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nirmala Bhoopalam. The network helps show where Nirmala Bhoopalam may publish in the future.

Co-authorship network of co-authors of Nirmala Bhoopalam

This figure shows the co-authorship network connecting the top 25 collaborators of Nirmala Bhoopalam. A scholar is included among the top collaborators of Nirmala Bhoopalam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nirmala Bhoopalam. Nirmala Bhoopalam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Smith, Matthew R., Susan Halabi, Charles J. Ryan, et al.. (2014). Randomized Controlled Trial of Early Zoledronic Acid in Men With Castration-Sensitive Prostate Cancer and Bone Metastases: Results of CALGB 90202 (Alliance). Journal of Clinical Oncology. 32(11). 1143–1150. 168 indexed citations
3.
Campbell, Steven C., Nirmala Bhoopalam, Thomas Moritz, et al.. (2010). The Use of Zoledronic Acid in Men Receiving Androgen Deprivation Therapy for Prostate Cancer With Severe Osteopenia or Osteoporosis. Urology. 75(5). 1138–1143. 22 indexed citations
4.
Bhoopalam, Nirmala, Steven C. Campbell, Thomas Moritz, et al.. (2009). Intravenous Zoledronic Acid to Prevent Osteoporosis in a Veteran Population With Multiple Risk Factors for Bone Loss on Androgen Deprivation Therapy. The Journal of Urology. 182(5). 2257–2264. 53 indexed citations
5.
Bhoopalam, Nirmala, et al.. (2008). Hemolytic Anemia From Ceftriaxone in an Elderly Patient: A Case Report. Journal of the American Medical Directors Association. 9(8). 610–611. 11 indexed citations
6.
Bhoopalam, Nirmala, Thomas Moritz, Harinder S. Garewal, et al.. (2008). A PHASE III TRIAL OF ZOLEDRONIC ACID (Z) TO PREVENT OSTEOPOROSIS IN MEN ON EARLY VS. PROLONGED ANDROGEN DEPRIVATION THERAPY (ADT) IN A HIGH RISK VA POPULATION. The Journal of Urology. 179(4S). 252–252.
7.
Schmitt, Brian P., et al.. (2008). Using Patient Traffic Control to Reduce Treatment Delays for High-Risk Patients at a VA Hospital. The Joint Commission Journal on Quality and Patient Safety. 34(3). 147–153. 1 indexed citations
8.
Talbot, Susan, Cathryn Rankin, Robert N. Taub, et al.. (2003). High‐dose ifosfamide with mesna and granuloctye–colony‐stimulating factor (recombinant human G‐CSF) in patients with unresectable malignant mesothelioma. Cancer. 98(2). 331–336. 3 indexed citations
9.
10.
Ellis, Thomas M., Phong T. Le, George H. DeVries, et al.. (2001). Alterations in CD30+ T Cells in Monoclonal Gammopathy of Undetermined Significance. Clinical Immunology. 98(3). 301–307. 3 indexed citations
11.
Bhoopalam, Nirmala, et al.. (1998). Fine-needle aspiration cytology of extraskeletal Ewing's sarcoma. Diagnostic Cytopathology. 18(2). 137–140. 15 indexed citations
12.
Wilson, John R., Nirmala Bhoopalam, & Morris A. Fisher. (1997). Hemolytic anemia associated with intravenous immunoglobulin. Muscle & Nerve. 20(9). 1142–1145. 50 indexed citations
13.
Thompson, Karen, et al.. (1997). Pleural effusion cytology of embryonal rhabdomyosarcoma. Diagnostic Cytopathology. 16(3). 270–273. 14 indexed citations
14.
Creekmore, Stephen P., James Harris, Thomas M. Ellis, et al.. (1989). A phase I clinical trial of recombinant interleukin-2 by periodic 24-hour intravenous infusions.. Journal of Clinical Oncology. 7(2). 276–284. 42 indexed citations
15.
Bhoopalam, Nirmala, et al.. (1985). Busulfan-induced suppression of natural killer cell activity.. PubMed. 13(11). 1127–32. 8 indexed citations
16.
Meyerstein, Naomi, et al.. (1980). The dependence of agglomeration of stored erythrocytes on fibrinogen and pH. Transfusion. 20(1). 101–104.
17.
Bhoopalam, Nirmala, Vincent Yakulis, Dario Giacomoni, & Paul Heller. (1976). Surface immunoglobulins of lymphocytes in mouse plasmacytoma. IV. Evidence for the persistence of the effect of plasmacytoma-RNA on the surface immunoglobulins of normal lymphocytes in vivo and in vitro.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 23(1). 139–48. 6 indexed citations
18.
Bhoopalam, Nirmala, et al.. (1976). Surface immunoglobulins of lymphocytes in plasmacytoma. V. The effect of RNA-rich extract from mouse plasmacytoma MOPC 104E on the immune response.. PubMed. 24(2). 357–67. 7 indexed citations
19.
Yakulis, Vincent, Nirmala Bhoopalam, & Paul Heller. (1972). The Production of Anti-Idiotypic Antibodies to BALB/c Plasmacytoma Globulins in BALB/c Mice. The Journal of Immunology. 108(4). 1119–1122. 36 indexed citations
20.
Bhoopalam, Nirmala, Vincent Yakulis, Nicolas Costea, & Paul Heller. (1971). Membrane Immunoglobulins of Lymphocytes in NZB Mice. The Journal of Immunology. 107(5). 1501–1503. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Butturini Breakdown of academic impact, for papers by Richard Delarue Breakdown of academic impact, for papers by Stella D’Oronzo Breakdown of academic impact, for papers by Fang Li Breakdown of academic impact, for papers by María‐Eugenia Miranda‐Carús Breakdown of academic impact, for papers by Shizuyo Tsujimura Breakdown of academic impact, for papers by J. Box Breakdown of academic impact, for papers by Marie-Joëlle Kaiser Breakdown of academic impact, for papers by Maria Melachrinou Breakdown of academic impact, for papers by Vincenzo Pitini
Rankless by CCL
2026